Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control
Sign Up to like & getrecommendations! Published in 2021 at "Diabetology International"
DOI: 10.1007/s13340-021-00508-3
Abstract: Aims The efficacy of dulaglutide was assessed according to the pretreatments administered before the initiation of dulaglutide in patients with type 2 diabetes. Methods In total, 89 patients treated using dulaglutide (0.75 mg, once a weekly)… read more here.
Keywords: group; type diabetes; daily glp; glp ras ... See more keywords